98 related articles for article (PubMed ID: 17274057)
1. Cyclooxygenase-2 expression in medullary thyroid carcinoma.
Popovtzer A; Morgenstein S; Roizman P; Gutman D; Bahar G; Stern Y; Feinmesser R
Head Neck; 2007 Jun; 29(6):559-63. PubMed ID: 17274057
[TBL] [Abstract][Full Text] [Related]
2. Assessment of cyclin D1 gene expression as a prognostic factor in benign and malignant thyroid lesions.
Brzeziańska E; Cyniak-Magierska A; Sporny S; Pastuszak-Lewandoska D; Lewiński A
Neuro Endocrinol Lett; 2007 Aug; 28(4):341-50. PubMed ID: 17693985
[TBL] [Abstract][Full Text] [Related]
3. Increased calcitonin level in thyroid nodules without medullary carcinoma.
Gibelin H; Essique D; Jones C; Levillain P; Maréchaud R; Kraimps JL
Br J Surg; 2005 May; 92(5):574-8. PubMed ID: 15779075
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 expression in primary thyroid carcinomas.
Sporny S; Slowinska-Klencka D; Ratynska M
Neuro Endocrinol Lett; 2005 Dec; 26(6):815-8. PubMed ID: 16380680
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinase 2 (TIMP-2) in medullary thyroid carcinoma: prognostic implications.
Cavalheiro BG; Junqueira CR; Brandão LG
Thyroid; 2008 Aug; 18(8):865-71. PubMed ID: 18651826
[TBL] [Abstract][Full Text] [Related]
6. Her2/neu expression in C-cell hyperplasia and medullary thyroid carcinomas.
Ensinger C; Prommegger R; Kendler D; Gabriel M; Spizzo G; Mikuz G; Kremser R
Anticancer Res; 2003; 23(3B):2241-3. PubMed ID: 12894498
[TBL] [Abstract][Full Text] [Related]
7. Role of FNA cytology and immunochemistry in the diagnosis and management of medullary thyroid carcinoma: report of six cases and review of the literature.
Bhanot P; Yang J; Schnadig VJ; Logroño R
Diagn Cytopathol; 2007 May; 35(5):285-92. PubMed ID: 17427218
[TBL] [Abstract][Full Text] [Related]
8. Expression of cyclooxygenase-2 by equine ocular and adnexal squamous cell carcinomas.
Smith KM; Scase TJ; Miller JL; Donaldson D; Sansom J
Vet Ophthalmol; 2008 Sep; 11 Suppl 1():8-14. PubMed ID: 19046264
[TBL] [Abstract][Full Text] [Related]
9. Medullary thyroid carcinoma with a paraganglioma-like pattern and melanin production: a case report with ultrastructural and immunohistochemical studies.
Ikeda T; Satoh M; Azuma K; Sawada N; Mori M
Arch Pathol Lab Med; 1998 Jun; 122(6):555-8. PubMed ID: 9625426
[TBL] [Abstract][Full Text] [Related]
10. [Expression of mucin-l and beta-catenin in papillary thyroid carcinoma and the clinical significance thereof].
He F; Li H; Li WS; Dong XH
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):393-6. PubMed ID: 19567117
[TBL] [Abstract][Full Text] [Related]
11. Medullary thyroid carcinoma with melanin production--a case report.
Singh ZN; Ray R; Kumar N; Aron M; Gupta SD
Indian J Pathol Microbiol; 1999 Apr; 42(2):159-63. PubMed ID: 10639777
[TBL] [Abstract][Full Text] [Related]
12. [Expression of cyclooxygenase-2 and urokinase plasminogen activator in gastric carcinoma and the clinical significance thereof].
Zhang FH; Zhou YN; Li GZ; Li Q; Lu B; Zhang ZY; Wu ZQ; Fan P; Hao TJ
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(46):3279-82. PubMed ID: 19159555
[TBL] [Abstract][Full Text] [Related]
13. Expression of cyclooxygenase and lipoxygenase enzymes in nasal polyps of aspirin-sensitive and aspirin-tolerant patients.
Owens JM; Shroyer KR; Kingdom TT
Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):579-87. PubMed ID: 16785401
[TBL] [Abstract][Full Text] [Related]
14. Ratio of metalloproteinase 2 to tissue inhibitor of metalloproteinase 2 in medullary thyroid carcinoma.
Cavalheiro BG; Junqueira CR; Brandão LG
Arch Otolaryngol Head Neck Surg; 2009 Aug; 135(8):812-7. PubMed ID: 19687404
[TBL] [Abstract][Full Text] [Related]
15. Secretory activity in medullary thyroid carcinoma: a cytomorphological and immunocytochemical study.
Das DK; Mallik MK; George SS; Sheikh ZA; Pathan SK; Haji BE; Al-Quaddomi SA; Mirza K; Ajrawi MT; Amir T; Dey P; Francis IM
Diagn Cytopathol; 2007 Jun; 35(6):329-37. PubMed ID: 17497663
[TBL] [Abstract][Full Text] [Related]
16. OPG, RANK and RANK ligand expression in thyroid lesions.
Heymann MF; Riet A; Le Goff B; Battaglia S; Paineau J; Heymann D
Regul Pept; 2008 Jun; 148(1-3):46-53. PubMed ID: 18367263
[TBL] [Abstract][Full Text] [Related]
17. Immunoexpression of multidrug-resistance protein 2 and cyclooxygenase 2 in medullary thyroid carcinomas.
Ruggeri RM; Sciacchitano S; Vitarelli E; Trimarchi F; Barresi G; Trovato M
Arch Pathol Lab Med; 2006 Jul; 130(7):1014-9. PubMed ID: 16831027
[TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical survey of nine cases of medullary carcinoma of thyroid including reactivity for Cox-1 and Cox-2 enzymes.
Bell CD; Vidal S; Kovacs K; Horvath E; Rotondo F
Endocr Pathol; 2002; 13(4):331-40. PubMed ID: 12665651
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase 2 expression in pterygium.
Chiang CC; Cheng YW; Lin CL; Lee H; Tsai FJ; Tseng SH; Tsai YY
Mol Vis; 2007 Apr; 13():635-8. PubMed ID: 17515883
[TBL] [Abstract][Full Text] [Related]
20. Hyalinizing trabecular adenoma--an uncommon thyroid tumor frequently misdiagnosed as papillary or medullary thyroid carcinoma.
Evenson A; Mowschenson P; Wang H; Connolly J; Mendrinos S; Parangi S; Hasselgren PO
Am J Surg; 2007 Jun; 193(6):707-12. PubMed ID: 17512281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
